{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:07:32Z","timestamp":1789420052634,"version":"build-2803163510"},"reference-count":2,"publisher":"American College of Physicians","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.7326\/annals-26-03132-jc","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:00:37Z","timestamp":1788210037000},"page":"JC102","source":"Crossref","is-referenced-by-count":0,"title":["In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d"],"prefix":"10.7326","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-9078","authenticated-orcid":false,"given":"Zaid","family":"Alsaaran","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, and King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Calgary, Alberta, Canada, and Riyadh, Saudi Arabia (Z.A.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hill","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, and Hotchkiss Brain Institute, Calgary, Alberta, Canada (M.D.H.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4285","reference":[{"key":"ANNALS-26-03132-R1","unstructured":"Prabhakaran S, Gonzalez NR, Zachrison KS, et al; Peer Review Committee.\n                      2026 guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2026;57:e316-e436. [PMID: 41582814]"},{"key":"ANNALS-26-03132-R2","doi-asserted-by":"crossref","unstructured":"Wu C, Sun C, Wang L, et al.\n                      Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis. Stroke. 2019;50:3481-3487. [PMID: 31570084]","DOI":"10.1161\/STROKEAHA.119.026240"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-26-03132-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-26-03132-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:01:28Z","timestamp":1789419688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-26-03132-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.7326\/ANNALS-26-03132-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-26-03132-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}